Detection of K76T mutation in pfcrt gene as an applicable genetic marker for prediction of chloroquine resistant falciparum malaria in isolates from an endemic district of Iran

Iranian Journal of Parasitology

Volumn 3, Issue 2, 2008, Pages 48-56

  Esmaeili Rastaghi, A R ^a,b   Nateghpour, M ^a   Assmar, M ^b   Razavi, M R ^b   Kanbara, H ^c   Uemura, H ^c   Naddaf, S R ^b   Keshavarz, H ^a   Raeisi, A ^d   Mohebali, M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c NAGASAKI UNIVERSITY   (Japan)

^d National Malaria Control Programme   (Iran)

Author keywords

Chloroquine resistance; Iran; K76T; pfcrt; Plasmodium falciparum

Indexed keywords

CHLOROQUINE; LYSINE; PROTEIN PFCRT; PROTOZOAL PROTEIN; THREONINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENDEMIC DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IN VIVO STUDY; IRAN; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MARKER GENE; MUTATIONAL ANALYSIS; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; POLYMERASE CHAIN REACTION; PREDICTION; PREVALENCE; SENSITIVITY AND SPECIFICITY; WILD TYPE;

PLASMODIUM FALCIPARUM;

EID: 67651198959     PISSN: 17357020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bray PG, Mungthin M, Ridley RG, Ward SA. Access to hematin: the basis of chloroquine resistance. Mol Pharmacol. 1998; 54(1):170-179.
2. Wellems TE, Plowe CV. Chloroquine-resistant malaria. J Infect Dis. 2001;184(6): 770-776.
3. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE. Mutations in the P. falciparum digestive vacuole transmembrane protein PFCRT and evidence for their role in chloroquine resistance. Mol Cell.2000; 6(4):861-871.
4. Wellems TE, Walker-Jonah A, Panton LJ. Genetic mapping of the cbloroquine-resistance locus on Plasmodium falciparum chromosome 7. Proc Natl Acad Sci USA. 1991;88(8):3382-33866.
5. Su X, Kirkman LA, Fujioka H, Wellems TE. Complex polymorphisms in an approximately 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell. 1997;91(5): 593-603.
6. Mehlotra RK, Fujioka H, Roepe PD, Janneh O, Ursos LM, Jacobs-Lorena V, McNamara DT, Bockarie MJ, Kazura JW, Kyle DE, 6.Fidock DA, Zimmerman PA. Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America. Proc Natl Acad Sci USA. 2001;98(22): 12689-12694.
7. Djimde A, Doumbo OK, Cortese JF, Kaventano K, Doumbo S, Diourte Y, Dicko A,Su Xz,Nomura T,Fidock DA, Wellems TE,Plowe CV,Coulibalv D. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001; 344(4):257-263
8. Pillai DR, Labbe AC, Vanisaveth V, Hongvangthong B, Pomphida S, Inkathone S, Zhong K, Kain KC. Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. J Infect Dis. 2001; 183(5):789-795.
9. Mayor AG, Gomez-Olive X, Aponte JJ, Casimiro S, Mabunda S, Dgedge M, Barreto A, Alonso PL. Prevalence of the K76T mutation in the putative Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene and its relation to chloroquine resistance in Mozambique. J Infect Dis. 2001;183(9):1413-1416.
10. Dorsey G, Kamya MR, Singh A, Rosenthal PJ. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kbmpala, Uganda. J Infect Dis. 2001; 183(9):1417-1420.
11. Babiker HA, Pringle SJ, Abdel-Muhsin A, Mackinnon M, Hunt P, Walliker D. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance gene pfmdr1. J Infect Dis. 2001;183(10):1535-1538.
12. Chen N, Russell B, Staley J, Kotecka B, Nasveld P, Cheng Q. Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum. J Infect Dis. 2001;183(10): 1543-1545.
13. Durand R, Jafari S, Vauzelle J, Delabre JF, Jesic Z, Le Bras J. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. Mol Biochem Parasitol. 2001;114(1): 95-102.
14. Goldberg DE, Slater AF, Cerami A, Henderson GB. Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc Natl Acad Sci USA. 1990; 87(8):2931-2935.
15. Dzekunov SM, Ursos LM, Roepe PD. Digestive vacuolar PH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine. Mol Biochem Parasitol. 2000;110(1):107-124.
16. Sanchez CP, McLean JE, Rohrbach P, Fidock DA, Stein WD, Lanzer M. Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry. 2005; 44(29):9862-9870.
17. Anderson TJ, Nair S, Qin H, Singlam S, Brockman A, Paiphun L, Nosten F. Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? Antimicrob Agents Chemother. 2005;49(6):2180-2188.
18. Duraisingh MT, Cowman AF. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 2005;94(3):181-190.
19. Edrissian GH, Shahabi S. Preliminary study of the response of Plasmodium falciparum to chloroquine in Sistan and Bluchistan province of Iran. Trans R Soc Trop Med Hyg. 1985;79(4):563-564.
20. Edrissian GH, Afshar A, Kanani A, Satvat MT, Mohsseni G, Nasseri-Nejad K, Emadi AM, Ghorbani M. The response of Plasmodium falciparum to chloroquine and mefloquine in Bandar-Abbas and Minab areas, Hormozgan province, southern Iran. J Trop Med & Hyg. 1989;92(2):75-79.
21. Edrissian GH. Status of the response of Plasmodium falciparum to chloroquine in Iran. Trop Geogr Med. 1989;41(4):297-303.
22. The work of WHO in the Eastern Mediterranean Region. Annual report of regional director. WHO Regional office for the Eastern Mediterranean. Alexandria. 2005. Available from: www.emro.who.int
23. Sadrizadeh B. Malaria in the world, in the eastern Mediterranean region and in Iran: Review article. WHO/EMRO Report 2001; 1-13.
24. Zakeri S, Najafabadi S, Zare A, Djadid DN. Detection of malaria parasites by nested PCR in southeastern, Iran: Evidence of highly mixed infections in Chahbahar district. Malar J. 2002;8(1):2-6.
25. Ursing J, Zakeri S, Gil JP, Bjorkman A. Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of Plasmodium falciparum in Iran. Acta Trop. 2006;97(3):352-356.
26. Eskandarian AA, Keshavarz H, Basco LK, Mahboudi F. Do mutations in Plasmodium falciparum dihydropteroate synthase and dihydrofolate reductase confer resistance to Sulfadoxine-Pyrimethamine in Iran? Trans R Soc Trop Med Hyg. 2002; 96(1):96-98.
27. Heidari A, Dittrich S, Jelink T, Kheirandish A, Banihashemi K, Keshavarz H. Genotypes and in vivo resistance of Plasmodium falciparum isolates in an endemic region of Iran. Parasitol.Res. 2006;100(3): 589-592.
28. Raeisi A, Ringwald P, Safa O, Shbazi A, Ranjbar M, Keshavarz H, Nateghpour M, Faraji L. Monitoring of the therapeutic efficacy of chloroquine for the treatment of uncomplicated, Plasmodium falciparum malaria in Iran. Ann Trop Med Parasitol. 2006; 100(1):11-16.
29. World Health Organization. Severe and complicated malaria. Division of Control of Tropical Diseases. Trans R Soc Trop Med Hyg. 1990;84(Supp12):1-65.
30. Djimde A, Doumbo OK, Steketee RW, Plowe CV. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet. 2001; 358(9285):890-891.
31. Jafari S, Le Bras J, Asmar M, Durand R. Molecular survey of Plasmodium falciparum resistance in south-eastern Iran. Ann Trop Med Parasitol. 2003;97(2):119-124.
32. Plowe CV. Monitoring drug resistance making the most of tools at hand. J Exp Biol. 2003;206:3745-3752.
33. Khalil IF, Alifrangis M, Tarimo DS, Staalso T, Satti GMH, Thenander TG, Ronn AM, Bygbjerg IC. The role of pfcrt 76T and pfmdr-1 86Y mutations, immunity and the initial level of parasitemia, in predicting the outcome of chloroquine treatment in two areas with different transmission intensities. Ann Trop Med Parasitol. 2005;97(2):441-448.